This Red  Journal activity provides practitioners with the knowledge needed to identify patients appropriate for PBI and counsel on efficacy and toxicity of modern techniques.

This Advances in Radiation Oncology Journal activity provides practitioners with the knowledge needed to appropriately treat patients receiving newer targeted therapies with hypofractionated and/or stereotactic radiation.

This journal activity provides practitioners with the knowledge about expected outcomes after SABR for oligometastatic cancers for patients with various histologies and prognostic factors and will help then better select patients for this treatment..

This journal activity provides practitioners with the knowledge about standard techniques and doses for the treatment post-operative bladder cancer.

This journal activity provides practitioners with the knowledge in understanding whether radiotherapy when given with Cyclin-Dependent Kinase (CDK) 4/6 inhibitors is associated with a different toxicity profile than radiotherapy alone.

This journal activity provides practitioners with the knowledge about standard techniques and doses for the treatment of grade 2 and grade 3 diffuse gliomas.

This journal activity provides practitioners with the knowledge needed to discuss the use of low dose radiation therapy for osteoarthritis with patients, expectations for relief following treatment, and how to plan the radiation.

This journal activity provides practitioners with the knowledge regarding recent treatment advances in lung cancer, including factors that may influence survival in patients with brain metastases with NSCLC and SCLC. It will also quantify how these factors impact survival.

This Advances in Radiation Oncology Journal activity provides practitioners with the knowledge needed to appropriately utilize palliative QUAD radiotherapy for elderly or frail patients.

This journal activity provides practitioners with the knowledge regarding a modern systematic compilation of radiobiological and clinical effects of average and instantaneous dose rates in the range covering brachytherapy to modern FLASH using linear accelerator electrons.